A lot of making goes on in this community these days, but sometimes you’ve just gotta do some old fashioned hacking. You might have grabbed an old Speak and Spell that you want to repurpose ...
Women in England with a specific type of endometrial cancer will be able to access an immunotherapy for the first time, after NICE backed use of GlaxoSmithKline's PD-1 inhibitor Jemperli via the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results